We have previously shown the opposing effects of variants in CDKN1C/CDKN1C, whereby gain of function of this cell cycle repressor is associated with adrenal hypoplasia and IMAGe syndrome and loss of function is associated with Beckwith-Wiedemann syndrome with an adrenal neoplasm risk (59). This evidence concerns the gene CDKN1C and adrenal gland neoplasm.